查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
基於NGS的RNA定序的全球市場（2024-2028）
市場調查報告書
商品編碼
1583994

基於NGS的RNA定序的全球市場（2024-2028）

Global Ngs-based Rna-seq Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 169 Pages | 訂單完成後即時交付

價格

基於NGS的RNA定序市場（2024-2028）

基於 NGS 的 RNA定序市場預計將以 20.52% 的複合年成長率成長，在 2023 年至 2028 年期間達到 66.59 億美元。研究報告包括基於 NGS 的 RNA定序市場的總體分析、市場規模和預測、趨勢、成長促進因素和挑戰，以及涵蓋約 25 家供應商的供應商分析。

該報告提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由次世代定序方法的日益採用、定序平台的技術進步以及各種次世代定序產品的可用性所推動的。

市場範圍
基準年 2024年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
與前一年同期比較（2024 年） 18.09%
複合年成長率 20.52%
增量 66.59億美元

該報告指出，下一代定序技術的進步是未來幾年推動基於 NGS 的 RNA定序市場成長的關鍵原因之一。此外，基因定序成本的降低以及生物資訊學和雲端基礎的軟體程式的開發將帶來巨大的市場需求。

目錄

第1章執行摘要

  • 市場概況

第2章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第3章 市場規模評估

  • 市場定義
  • 細分市場分析
  • 市場規模（2023年）
  • 市場展望（2023-2028）

第4章 市場規模表現

  • 基於NGS的RNA定序的全球市場（2018-2022）
  • 最終用戶分析（2018-2022）
  • 依技術分析（2018-2022）
  • 區域分析（2018-2022）
  • 國家分析（2018-2022）

第5章五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第6章 最終用戶的市場區隔

  • 市場區隔
  • 比較：按最終用戶
  • 學術研究中心：市場規模與預測（2023-2028）
  • 臨床研究：市場規模與預測（2023-2028）
  • 製藥公司：市場規模及預測（2023-2028）
  • 醫院：市場規模與預測（2023-2028）
  • 最終用戶的市場機會

第7章 按技術細分市場

  • 市場區隔
  • 比較：按技術
  • 合成定序：市場規模與預測（2023-2028）
  • 離子半導體定序：市場規模與預測（2023-2028）
  • 單分子即時定序：市場規模及預測（2023-2028）
  • 其他：市場規模及預測（2023-2028）
  • 科技帶來的市場機會

第8章 客戶狀況

  • 客戶狀況概覽

第9章 地區情勢

  • 區域細分
  • 區域比較
  • 北美：市場規模與預測（2023-2028）
  • 歐洲：市場規模與預測（2023-2028）
  • 亞洲：市場規模與預測（2023-2028）
  • 世界其他地區：市場規模與預測（2023-2028）
  • 美國：市場規模與預測（2023-2028）
  • 英國：市場規模與預測（2023-2028）
  • 德國：市場規模與預測（2023-2028）
  • 新加坡：市場規模與預測（2023-2028）
  • 中國：市場規模及預測（2023-2028）
  • 按地區分類的市場機會

第10章 促進因素、挑戰、機會、限制因素

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機會與限制

第11章競爭格局

  • 概述
  • 競爭格局
  • 混亂的情況
  • 產業風險

第12章 競爭分析

  • 公司簡介
  • 公司市場定位
  • Agilent Technologies Inc.
  • Azenta Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Hamilton Co.
  • Illumina Inc.
  • Pacific Biosciences of California Inc.
  • Perkin Elmer Inc.
  • Psomagen Inc.
  • QIAGEN NV
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.

第13章附錄

Product Code: IRTNTR74727

NGS-based RNA-seq Market 2024-2028

The NGS-based RNA-seq market is forecasted to grow by USD 6659 mn during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202418.09%
CAGR20.52%
Incremental Value$6659 mn

Technavio's NGS-based RNA-seq market is segmented as below:

By End-user

    • Acamedic and research centers
    • Clinical research
    • Pharma companies
    • Hospitals

By Technology

    • Sequencing by synthesis
    • Ion semiconductor sequencing
    • Single-molecule real-time sequencing
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

    • NGS-based RNA-seq market sizing
    • NGS-based RNA-seq market forecast
    • NGS-based RNA-seq market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp.. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global NGS-Based RNA-Seq Market 2018 - 2022
    • Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
  • 4.2 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Technology segment analysis 2018 - 2022
    • Historic Market Size - Technology Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 6.3 Acamedic and research centers - Market size and forecast 2023-2028
    • Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
    • Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
    • Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
    • Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • 6.4 Clinical research - Market size and forecast 2023-2028
    • Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
    • Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
    • Chart on Clinical research - Year-over-year growth 2023-2028 (%)
    • Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
  • 6.5 Pharma companies - Market size and forecast 2023-2028
    • Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
    • Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
  • 6.6 Hospitals - Market size and forecast 2023-2028
    • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 6.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

  • 7.1 Market segments
    • Chart on Technology - Market share 2023-2028 (%)
    • Data Table on Technology - Market share 2023-2028 (%)
  • 7.2 Comparison by Technology
    • Chart on Comparison by Technology
    • Data Table on Comparison by Technology
  • 7.3 Sequencing by synthesis - Market size and forecast 2023-2028
    • Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
    • Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
    • Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
    • Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • 7.4 Ion semiconductor sequencing - Market size and forecast 2023-2028
    • Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
    • Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
    • Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
    • Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • 7.5 Single-molecule real-time sequencing - Market size and forecast 2023-2028
    • Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
    • Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
    • Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
    • Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • 7.6 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.7 Market opportunity by Technology
    • Market opportunity by Technology ($ million)
    • Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 Singapore - Market size and forecast 2023-2028
    • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
    • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
    • Chart on Singapore - Year-over-year growth 2023-2028 (%)
    • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
  • 9.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
  • 12.4 Azenta Inc.
    • Azenta Inc. - Overview
    • Azenta Inc. - Business segments
    • Azenta Inc. - Key news
    • Azenta Inc. - Key offerings
    • Azenta Inc. - Segment focus
  • 12.5 BGI Genomics Co. Ltd.
    • BGI Genomics Co. Ltd. - Overview
    • BGI Genomics Co. Ltd. - Product / Service
    • BGI Genomics Co. Ltd. - Key offerings
  • 12.6 Eurofins Scientific SE
    • Eurofins Scientific SE - Overview
    • Eurofins Scientific SE - Business segments
    • Eurofins Scientific SE - Key news
    • Eurofins Scientific SE - Key offerings
    • Eurofins Scientific SE - Segment focus
  • 12.7 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 12.8 Hamilton Co.
    • Hamilton Co. - Overview
    • Hamilton Co. - Product / Service
    • Hamilton Co. - Key offerings
  • 12.9 Illumina Inc.
    • Illumina Inc. - Overview
    • Illumina Inc. - Business segments
    • Illumina Inc. - Key news
    • Illumina Inc. - Key offerings
    • Illumina Inc. - Segment focus
  • 12.10 Pacific Biosciences of California Inc.
    • Pacific Biosciences of California Inc. - Overview
    • Pacific Biosciences of California Inc. - Product / Service
    • Pacific Biosciences of California Inc. - Key offerings
  • 12.11 Perkin Elmer Inc.
    • Perkin Elmer Inc. - Overview
    • Perkin Elmer Inc. - Business segments
    • Perkin Elmer Inc. - Key news
    • Perkin Elmer Inc. - Key offerings
    • Perkin Elmer Inc. - Segment focus
  • 12.12 Psomagen Inc.
    • Psomagen Inc. - Overview
    • Psomagen Inc. - Product / Service
    • Psomagen Inc. - Key offerings
  • 12.13 QIAGEN NV
    • QIAGEN NV - Overview
    • QIAGEN NV - Product / Service
    • QIAGEN NV - Key news
    • QIAGEN NV - Key offerings
  • 12.14 Takara Bio Inc.
    • Takara Bio Inc. - Overview
    • Takara Bio Inc. - Product / Service
    • Takara Bio Inc. - Key offerings
  • 12.15 Tecan Trading AG
    • Tecan Trading AG - Overview
    • Tecan Trading AG - Business segments
    • Tecan Trading AG - Key news
    • Tecan Trading AG - Key offerings
    • Tecan Trading AG - Segment focus
  • 12.16 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
  • 12.17 Zymo Research Corp.
    • Zymo Research Corp. - Overview
    • Zymo Research Corp. - Product / Service
    • Zymo Research Corp. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by End-user
  • Exhibits35: Data Table on Comparison by End-user
  • Exhibits36: Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Market opportunity by End-user ($ million)
  • Exhibits53: Data Table on Market opportunity by End-user ($ million)
  • Exhibits54: Chart on Technology - Market share 2023-2028 (%)
  • Exhibits55: Data Table on Technology - Market share 2023-2028 (%)
  • Exhibits56: Chart on Comparison by Technology
  • Exhibits57: Data Table on Comparison by Technology
  • Exhibits58: Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Market opportunity by Technology ($ million)
  • Exhibits75: Data Table on Market opportunity by Technology ($ million)
  • Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits79: Chart on Geographic comparison
  • Exhibits80: Data Table on Geographic comparison
  • Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Market opportunity By Geographical Landscape ($ million)
  • Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits119: Impact of drivers and challenges in 2023 and 2028
  • Exhibits120: Overview on criticality of inputs and factors of differentiation
  • Exhibits121: Overview on factors of disruption
  • Exhibits122: Impact of key risks on business
  • Exhibits123: Companies covered
  • Exhibits124: Matrix on companies position and classification
  • Exhibits125: Agilent Technologies Inc. - Overview
  • Exhibits126: Agilent Technologies Inc. - Business segments
  • Exhibits127: Agilent Technologies Inc. - Key news
  • Exhibits128: Agilent Technologies Inc. - Key offerings
  • Exhibits129: Agilent Technologies Inc. - Segment focus
  • Exhibits130: Azenta Inc. - Overview
  • Exhibits131: Azenta Inc. - Business segments
  • Exhibits132: Azenta Inc. - Key news
  • Exhibits133: Azenta Inc. - Key offerings
  • Exhibits134: Azenta Inc. - Segment focus
  • Exhibits135: BGI Genomics Co. Ltd. - Overview
  • Exhibits136: BGI Genomics Co. Ltd. - Product / Service
  • Exhibits137: BGI Genomics Co. Ltd. - Key offerings
  • Exhibits138: Eurofins Scientific SE - Overview
  • Exhibits139: Eurofins Scientific SE - Business segments
  • Exhibits140: Eurofins Scientific SE - Key news
  • Exhibits141: Eurofins Scientific SE - Key offerings
  • Exhibits142: Eurofins Scientific SE - Segment focus
  • Exhibits143: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits145: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits148: Hamilton Co. - Overview
  • Exhibits149: Hamilton Co. - Product / Service
  • Exhibits150: Hamilton Co. - Key offerings
  • Exhibits151: Illumina Inc. - Overview
  • Exhibits152: Illumina Inc. - Business segments
  • Exhibits153: Illumina Inc. - Key news
  • Exhibits154: Illumina Inc. - Key offerings
  • Exhibits155: Illumina Inc. - Segment focus
  • Exhibits156: Pacific Biosciences of California Inc. - Overview
  • Exhibits157: Pacific Biosciences of California Inc. - Product / Service
  • Exhibits158: Pacific Biosciences of California Inc. - Key offerings
  • Exhibits159: Perkin Elmer Inc. - Overview
  • Exhibits160: Perkin Elmer Inc. - Business segments
  • Exhibits161: Perkin Elmer Inc. - Key news
  • Exhibits162: Perkin Elmer Inc. - Key offerings
  • Exhibits163: Perkin Elmer Inc. - Segment focus
  • Exhibits164: Psomagen Inc. - Overview
  • Exhibits165: Psomagen Inc. - Product / Service
  • Exhibits166: Psomagen Inc. - Key offerings
  • Exhibits167: QIAGEN NV - Overview
  • Exhibits168: QIAGEN NV - Product / Service
  • Exhibits169: QIAGEN NV - Key news
  • Exhibits170: QIAGEN NV - Key offerings
  • Exhibits171: Takara Bio Inc. - Overview
  • Exhibits172: Takara Bio Inc. - Product / Service
  • Exhibits173: Takara Bio Inc. - Key offerings
  • Exhibits174: Tecan Trading AG - Overview
  • Exhibits175: Tecan Trading AG - Business segments
  • Exhibits176: Tecan Trading AG - Key news
  • Exhibits177: Tecan Trading AG - Key offerings
  • Exhibits178: Tecan Trading AG - Segment focus
  • Exhibits179: Thermo Fisher Scientific Inc. - Overview
  • Exhibits180: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits181: Thermo Fisher Scientific Inc. - Key news
  • Exhibits182: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits183: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits184: Zymo Research Corp. - Overview
  • Exhibits185: Zymo Research Corp. - Product / Service
  • Exhibits186: Zymo Research Corp. - Key offerings
  • Exhibits187: Inclusions checklist
  • Exhibits188: Exclusions checklist
  • Exhibits189: Currency conversion rates for US$
  • Exhibits190: Research methodology
  • Exhibits191: Information sources
  • Exhibits192: Data validation
  • Exhibits193: Validation techniques employed for market sizing
  • Exhibits194: Data synthesis
  • Exhibits195: 360 degree market analysis
  • Exhibits196: List of abbreviations